In the seventh Exponential Investor podcast, I speak to Kevin Lustig, the CEO of Assay Depot. Kevin's company could revolutionise the pharmaceutical industry, making the entire research process cheaper and more transparent. His medical model would see pharma companies "outsource everything but the genius". So how does it work?